Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-26-001309
Filing Date
2026-05-06
Accepted
2026-05-06 21:16:29
Documents
1
Period of Report
2026-05-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es260776360_3-sptx2.html 3  
1 OWNERSHIP DOCUMENT es260776360_3-sptx2.xml 3 8892
  Complete submission text file 0000950142-26-001309.txt   12268
Mailing Address 55 EAST 52ND STREET, 32ND FLOOR NEW YORK NY 10055
Business Address 55 EAST 52ND STREET, 32ND FLOOR NEW YORK NY 10055 212 715 4000
GAP Coinvestments CDA, L.P. (Reporting) CIK: 0001356474 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-43254 | Film No.: 26950470

Mailing Address 55 EAST 52ND STREET FLOOR 33 NEW YORK NY 10055
Business Address 55 EAST 52ND STREET FLOOR 33 NEW YORK NY 10055 212-715-4000
General Atlantic Partners (Lux), SCSp (Reporting) CIK: 0001795410 (see all company filings)

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-43254 | Film No.: 26950469

Mailing Address 412F ROUTE D'ESCH LUXEMBOURG N4 2086
Business Address 412F ROUTE D'ESCH LUXEMBOURG N4 2086 212-715-4000
General Atlantic GenPar (Lux) SCSp (Reporting) CIK: 0001857517 (see all company filings)

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-43254 | Film No.: 26950467

Mailing Address 412F ROUTE D'ESCH LUXEMBOURG P7 10055
Business Address 412F ROUTE D'ESCH LUXEMBOURG P7 10055 212-715-4000
General Atlantic (Lux) S.a r.l. (Reporting) CIK: 0001858361 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-43254 | Film No.: 26950468

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Issuer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)